期刊文献+

康柏西普对增生性糖尿病视网膜病变患者氧化应激水平和炎症因子浓度的影响 被引量:16

The effection of anti-VEGF(Conbercept)on oxidative stress level and inflammatory factor concentration of aqueous humous in patients of proliferative diabetic retinopathy
下载PDF
导出
摘要 目的通过测定增生性糖尿病视网膜病变(PDR)患者玻璃体腔注射抗血管内皮生长因子(VEGF)药物前后,眼房水中白介素-6(IL-6)、人单核细胞趋化蛋白-1(MCP-1)和丙二醛(MDA)水平的变化及之间的相关性,探讨康柏西普对PDR患者房水中氧化应激水平和炎症因子浓度的影响。方法前瞻性临床研究。选取行玻璃体腔注射康柏西普,并行玻璃体切除术的PDR的患者共74例(75只眼)入组,其中男性35例,女性39例。每位患者在玻璃体注射康柏西普之前,前房穿刺取未经稀释的房水50~100μl;1周后在行玻璃体切除术之前,前房穿刺取未经稀释的房水50~100μl。排除有其他严重的心脏、肝、肾等全身疾病史者;有青光眼,葡萄膜炎等其他眼部疾病病史者;以前有过视网膜激光、玻璃体注射药物史,眼部手术史者。所有患者均检测玻璃体腔注射抗VEGF药前后眼房水中的IL-6、MCP-1、MDA浓度。结果玻璃体注射康柏西普7 d,房水中IL-6、MCP-1中位数水平(803.12 pg/ml、1213.28 pg/ml)较注射前(32.32 pg/ml,986.91 pg/ml)显著升高,差异有统计学意义(P<0.01);MDA中位数水平(20.63 pg/ml)较注射前(28.71 pg/ml)显著降低,差异有统计学意义(P<0.01)。Spearman’s相关分析显示,患者房水中IL-6和MCP-1浓度在注射康柏西普前后始终存在比较强的相关性,其中注射前r=0.681,P<0.001,注射后r=0.614,P<0.001。IL-6和MCP-1本身在注射前后也存在较强的相关性,其中IL-6注射前后r=0.376,P<0.05,MCP-1注射前后r=0.638,P<0.001。在注射康柏西普前,患者房水中MDA和MCP-1存在较强的相关性,r=0.651,P<0.001。MDA和IL-6也存在较强的相关性,r=0.530,P<0.05。在注射康柏西普后,没有发现MDA和MCP-1、IL-6的相关性。结论炎症反应与氧化应激之间的相互作用是PDR的发生发展中的一个比较重要的机制。 Objective The purpose of this study was to determine the levels of interleukin-6(IL-6),human monocyte chemoattractant protein-1(MCP-1)and malondialdehyde(MDA)in aqueous humor before and after intravitreal injection of anti-vascular endothelial growth factor(VEGF,Conbercept)in patients with proliferative diabetic retinopathy(PDR)and to discuss the correlation of these cytokines and MDA to further explore the effect of anti-vegf drug on oxidative stress level and inflammatory factor concentration in aqueous humor of patients with PDR.Methods Prospective clinical study.A total of 74 patients with proliferative diabetic retinopathy underwent pars plana vitrectomy(PPV)were enrolled in this study,including 35 males and 39 females.All the patients received intravitreal Conbercept theraphy 7 days before PPV.50~100μl of undiluted aqueous humor samples were collected at the time of intravitreal Conbercept and PPV treatment.Exclude patients with other serious history of heart,liver,kidney and other systemic diseases;glaucoma,uveitis and other history of eye diseases;previously had a history of retinal laser,vitreous injection,history of eye surgery.All patients were tested for IL-6,MCP-1,and MDA concentrations in the aqueous humor before and after intravitreal injection of anti-VEGF drugs.Results 7 days after intravitreal Conbercept,the levels of IL-6,MCP-1(803.12 pg/ml、1213.28 pg/ml)in aqueous humor were significantly higher than the levels of pre-operation(32.32±pg/ml,986.91 pg/ml),the difference was statistically significant(P<0.01).The levels of MDA(20.63 pg/ml)in aqueous humor were significantly lower than the levels of pre-operation(28.71 pg/ml),the difference was statistically significant(P<0.01).Spearman's correlation analysis showed that there were always strongly correlations between the concentrations of IL-6 and MCP-1 in the aqueous humor of the patients before and after the intravitreal Conbercept,including r=0.681 before injection,P<0.001,and r=0.614 after intravitreal injection,P<0.001.Il-6 and MCP-1 were also strongly correlated before and after intravitreal injection themselves,with IL-6 r=0.376,P<0.05,and MCP-1 r=0.638,P<0.001.We also find before the intravitreal Conbercept,there was a strong correlation between MDA and MCP-1 in the aqueous humor of patients,r=0.651,P<0.001.There was also a strong correlation between MDA and IL-6,r=0.530,P<0.05.No correlation between MDA,MCP-1,and IL-6 was found after intravitreal Conbercept.Conclusions The interaction between inflammatory mediators and oxidative stress may be an important mechanism in the development of proliferative diabetic retinopathy.
作者 黄玥 李旌 张茜 沈碧波 郑岩 Huang Yue;Li Jing;Zhang Qian;Sheng Bibo;Zheng Yan(Department of opthalmology,Chong Ming Hospital affiliated to Xin Hua Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 202150,China;Department of Opthalmology,Xin Hua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China)
出处 《临床眼科杂志》 2022年第1期5-10,共6页 Journal of Clinical Ophthalmology
关键词 康柏西普 增生性糖尿病视网膜病变 白介素-6 人单核细胞趋化蛋白-1 丙二醛 Conbercept interleukin-6 Proliferative diabetic retinopathy Human monocyte chemoattractant protein-1 Malondialdehyde
  • 相关文献

二级参考文献70

  • 1卢宁清,赵伟鸿,樊紫周,果嘉,程瑞凤,赵金英,王英华,彭晓东.宁夏栽培甘草的黄酮提取物降糖作用实验研究[J].宁夏医科大学学报,2013,35(5):510-514. 被引量:7
  • 2Sulochana KN,Ramakrishnan S,Rajesh M,Coral K,Badrinath SS.Diabetic retinopathy:molecular mechanisms,present regime of treatment and future prospectives.Curr Sci 2001;80(2):133-142.
  • 3Klein R,Klein BE,Moss SE,Davis MD,DeMets DL.The Wisconsin epidemiologic study of diabetic retinopathy.Ⅲ.Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.Arch Ophthalmol 1984;102(4):527-532.
  • 4Caine GJ,Blann AD,Stonelake PS,Ryan P,Lip GY.Plasma angiopoietin-1,angiopoietin-2 and Tie-2 in breast and prostate cancer:a comparison with VEGF and Flt-1.Eur J Clin Invest 2003;33(10):883-890.
  • 5Aeillo LP,Avery RL,Arigg PG,Keyt BA,Jampel HD,Shah ST,Pasguale LR,Thieme H,Iwamoto MA Park SE.Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders.N Engl J Med 1994;331(22):1480-1487.
  • 6Marsden PA,Heng HH,Scherer SW,Stewart RJ,Hall AV,Shi XM,Tsui LC,Schappert KT.Structure and chromosomal localization of the human constitutive endothelial ntric oxide synthase gene.J Biol Chem 1993;268(23):17478-17488.
  • 7Li H,Forstermann U.Nitric oxide in the pathogenesis of vascular disease.J Pathol 2000;190(3):244-254.
  • 8Mangiafico RA,Malatino LS,Santonocito M,Spada RS.(Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.Int Angiol 1998;17(2):97-102.
  • 9Chaturvedi N,Sjolie AK,Stephenson JM,Abrahamian H,Keipes M,Castellarin A,Rogulja-Pepeonik Z,Fuller JH.Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes.The EUCLID Study Group.EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.Lancet 1998;351(9095):28-31.
  • 10Pe'er J,Folberg R,Itin A,Gnessin H,Hemo I,Keshet E.Upregulated expression of vascular endothelial growth factor in prolifera-tive diabetic retinopathy.Br J Ophthalmol 1996;80 (3):241-245.

共引文献58

同被引文献197

引证文献16

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部